Journal
Clinical cancer research
Publication Date
4-14-2023
Volume
29
Issue
8
First Page
1592
Last Page
1604
Document Type
Open Access Publication
DOI
10.1158/1078-0432.CCR-22-3722
Rights and Permissions
Borcherding DC, Amin NV, He K, Zhang X, Lyu Y, Dehner C, Bhatia H, Gothra A, Daud L, Ruminski P, Pratilas CA, Pollard K, Sundby T, Widemann BC, Hirbe AC. MEK Inhibition Synergizes with TYK2 Inhibitors in NF1-Associated Malignant Peripheral Nerve Sheath Tumors. Clin Cancer Res. 2023 Apr 14;29(8):1592-1604. doi: 10.1158/1078-0432. This open access article is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license
Recommended Citation
Borcherding, Dana C; Amin, Neha V; He, Kevin; Zhang, Xiaochun; Lyu, Yang; Dehner, Carina; Bhatia, Himanshi; Gothra, Angad; Daud, Layla; Ruminski, Peter; Pratilas, Christine A; Pollard, Kai; Sundby, Taylor; Widemann, Brigitte C; and Hirbe, Angela C, "MEK inhibition synergizes with TYK2 inhibitors in NF1-associated malignant peripheral nerve sheath tumors." Clinical cancer research. 29, 8. 1592 - 1604. (2023).
https://digitalcommons.wustl.edu/oa_4/2017
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
